FR2528434B1 - Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament - Google Patents

Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament

Info

Publication number
FR2528434B1
FR2528434B1 FR8210205A FR8210205A FR2528434B1 FR 2528434 B1 FR2528434 B1 FR 2528434B1 FR 8210205 A FR8210205 A FR 8210205A FR 8210205 A FR8210205 A FR 8210205A FR 2528434 B1 FR2528434 B1 FR 2528434B1
Authority
FR
France
Prior art keywords
group
carbon atoms
hydrogen
alkyl
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8210205A
Other languages
English (en)
French (fr)
Other versions
FR2528434A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR8210205A priority Critical patent/FR2528434B1/fr
Priority to US06/501,373 priority patent/US4547493A/en
Priority to AT86200441T priority patent/ATE46702T1/de
Priority to AT83401178T priority patent/ATE23344T1/de
Priority to EP86200441A priority patent/EP0196707B1/fr
Priority to DE8383401178T priority patent/DE3367396D1/de
Priority to DE8686200441T priority patent/DE3380628D1/de
Priority to EP83401178A priority patent/EP0097572B1/fr
Priority to CA000430095A priority patent/CA1220780A/fr
Priority to JP58102979A priority patent/JPS5946299A/ja
Publication of FR2528434A1 publication Critical patent/FR2528434A1/fr
Application granted granted Critical
Publication of FR2528434B1 publication Critical patent/FR2528434B1/fr
Priority to US06/760,703 priority patent/US4634696A/en
Priority to US06/810,316 priority patent/US4978657A/en
Priority to FR8816996A priority patent/FR2640977A2/fr
Priority to US07/421,526 priority patent/US5043332A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8210205A 1981-01-09 1982-06-11 Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament Expired FR2528434B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR8210205A FR2528434B1 (fr) 1982-06-11 1982-06-11 Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US06/501,373 US4547493A (en) 1982-06-11 1983-06-06 Novel 11β-substituted-19-nor-steroids
EP83401178A EP0097572B1 (fr) 1982-06-11 1983-06-09 Nouveaux 19-nor stéroides substitués en 11 et éventuellement en 2,leur préparation, leur application comme médicaments, les compositions les renfermant et les nouveaux intermédiaires obtenus
EP86200441A EP0196707B1 (fr) 1982-06-11 1983-06-09 Nouveaux 19-nor stéroides substitués en 11, en 17 et éventuellement en 2, leur préparation, leur application comme médicaments, les compositions les renfermant et les nouveaux intermédiaires obtenus
DE8383401178T DE3367396D1 (en) 1982-06-11 1983-06-09 19-nor steroids substituted at position 11 and optionally at position 2, their preparation, their utilization as medicaments, compositions containing them and intermediates obtained
DE8686200441T DE3380628D1 (en) 1982-06-11 1983-06-09 19-nor steroids substituted at positions 11 and 17 and optionally at position 2, their preparation, their use as medicaments, compositions containing them and intermediates obtained
AT86200441T ATE46702T1 (de) 1982-06-11 1983-06-09 In stellung 11 und 17 und gegebenenfalls in stellung 2 substituierte 19-nor-steroide, ihre herstellung, ihre anwendung als arzneimittel, die sie enthaltenden zusammensetzungen und die erhaltenen zwischenprodukte.
AT83401178T ATE23344T1 (de) 1982-06-11 1983-06-09 In stellung 11 und gegebenenfalls in stellung 2 substituierte 19-nor steroide, ihre herstellung, ihre anwendung als arzneimittel, die zusammensetzungen, die sie enthalten und die erhaltenen zwischenprodukte.
CA000430095A CA1220780A (fr) 1982-06-11 1983-06-10 PROCEDE DE PREPARATION DE NOUVEAUX 19-NOR STEROIDES SUBSTITUES EN 11.beta. ET EVENTUELLEMENT EN 2
JP58102979A JPS5946299A (ja) 1982-06-11 1983-06-10 １１β及び２位が置換されている新規な１９―ノルステロイド、それらの製造方法及びこれらを含有する組成物
US06/760,703 US4634696A (en) 1982-06-11 1985-07-30 Novel 11 beta-substituted-19-nor-steroids
US06/810,316 US4978657A (en) 1981-01-09 1985-12-17 Novel 11β-substituted-19-nor-steroids
FR8816996A FR2640977A2 (en) 1982-06-11 1988-12-22 New position-11 substituted 19-norsteroids and their application as medicinal products.
US07/421,526 US5043332A (en) 1981-01-09 1989-10-13 Novel 11β-substituted -19-nor-steriods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210205A FR2528434B1 (fr) 1982-06-11 1982-06-11 Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
FR2528434A1 FR2528434A1 (fr) 1983-12-16
FR2528434B1 true FR2528434B1 (fr) 1985-07-19

Family

ID=9274893

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8210205A Expired FR2528434B1 (fr) 1981-01-09 1982-06-11 Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament

Country Status (7)

Country Link
US (2) US4547493A (cg-RX-API-DMAC7.html)
EP (2) EP0196707B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5946299A (cg-RX-API-DMAC7.html)
AT (1) ATE46702T1 (cg-RX-API-DMAC7.html)
CA (1) CA1220780A (cg-RX-API-DMAC7.html)
DE (1) DE3367396D1 (cg-RX-API-DMAC7.html)
FR (1) FR2528434B1 (cg-RX-API-DMAC7.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
DE3306121A1 (de) * 1983-02-18 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-spirolaktone in der steroidreihe, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2610933B1 (fr) * 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5686465A (en) * 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US6790971B1 (en) * 1989-02-24 2004-09-14 Aventis Pharma S.A. 19-Nor-steroids
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
GR1001164B (el) * 1989-07-07 1993-05-24 Endorecherche Inc Παραγωγα αρρενογονου ορμονης προς χρησιν εις την αναστολην δραστηριοτητος της στεροειδους ορμονης φυλου
WO1991000733A1 (en) * 1989-07-07 1991-01-24 Endorecherche Inc. Method of treatment of androgen-related diseases
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
FR2651435A1 (fr) * 1989-09-07 1991-03-08 Roussel Uclaf Nouvelle utilisation de composes anti-progestomimetiques.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
WO1993023053A1 (en) * 1992-05-21 1993-11-25 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
US5679788A (en) * 1993-06-17 1997-10-21 Roussel Uclaf 11 beta-substituted-19 nor-steroids
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
EP0683172B1 (en) * 1994-05-19 1997-08-13 Akzo Nobel N.V. 11,21-Bisphenyl-19-norpregnane derivatives
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
FR2780060B1 (fr) * 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
GB9910934D0 (en) * 1999-05-11 1999-07-14 Res Inst Medicine Chem Chemical compounds
FR2826004B1 (fr) 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
FR2854403B1 (fr) * 2003-04-29 2008-07-11 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes
AU2004249280A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Antiviral compositions and methods of using the same
PL1989218T3 (pl) * 2006-02-17 2010-06-30 Janssen Pharmaceutica Nv Pochodne 17-fosforosteroidów użyteczne jako modulatory receptora progesteronowego
DE102009034525A1 (de) * 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
EP2576582B1 (en) 2010-05-26 2019-09-18 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
WO2016140867A1 (en) 2015-03-02 2016-09-09 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors
EP3277281B1 (en) 2015-03-30 2022-01-05 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
MX383318B (es) 2015-08-13 2025-03-13 Corcept Therapeutics Inc Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina.
WO2017112904A1 (en) * 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CA3009525A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11124537B2 (en) 2015-12-23 2021-09-21 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
MX2018008849A (es) 2016-01-19 2019-01-31 Corcept Therapeutics Inc Diagnostico diferencial de sindrome de cushing ectopico.
EP3430065A1 (de) 2016-03-18 2019-01-23 Basf Se Feinteilige wässrige mehrstufige polymerisatdispersion, verfahren zu deren herstellung und deren verwendung als bindemittel
NZ753142A (en) 2016-10-07 2020-08-28 Oric Pharmaceuticals Inc Inhibitors of glucocorticoid receptor
WO2018183947A1 (en) 2017-03-31 2018-10-04 Corcept Therapeutics, Inc. Glucocorticoid receptor modulators to treat cervical cancer
EP3641780B1 (en) 2017-06-20 2025-09-10 Corcept Therapeutics Incorporated Treatment of neuroepithelial tumors using selective glucocorticoid receptor modulators
EP3941460B1 (en) 2019-03-18 2025-10-15 Nieman, Lynnette K. Mifepristone for use in improving insulin sensitivity
US20240269280A1 (en) 2020-12-18 2024-08-15 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CA1220780A (fr) 1987-04-21
US4547493A (en) 1985-10-15
EP0196707B1 (fr) 1989-09-27
EP0097572B1 (fr) 1986-11-05
ATE46702T1 (de) 1989-10-15
EP0196707A1 (fr) 1986-10-08
JPH0443077B2 (cg-RX-API-DMAC7.html) 1992-07-15
FR2528434A1 (fr) 1983-12-16
US4634696A (en) 1987-01-06
DE3367396D1 (en) 1986-12-11
JPS5946299A (ja) 1984-03-15
EP0097572A1 (fr) 1984-01-04

Similar Documents

Publication Publication Date Title
FR2528434B1 (fr) Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
MY100124A (en) Dihydropyridazinones.
AU543739B2 (en) Phenol derivatives
MY102087A (en) Phenethanolamine derivatives.
ES8703860A1 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES552796A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
ES8200122A1 (es) Un metodo para la preparacion de 17,21-diesteres de 6alfa- 9alfa-didluoro-16-metil-prednisolona
FR2394522A1 (fr) Nouveaux derives d'acides (s-phenenyl tris(carbonylimino))-5,5',5''tri-benzene-carboxyliques utiles notamment comme inhibiteurs du complement, et leur procede de preparation
ES8104323A1 (es) Un procedimiento para obtener 2,6-diaminonebularinas
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
ES8505167A1 (es) Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas.
GB1496692A (en) Process for the preparation of ceph-2-em compounds
ES554827A0 (es) Procedimiento para preparar acidos hexenoicos.
ES8604121A1 (es) Procedimiento para la preparacion de esteres de acido guani-dinobenzoico
ES8103730A1 (es) Procedimiento para la preparacion de una peptidamida
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
FR2361382A1 (fr) 2-vinyl-chromones substituees, utiles notamment comme anti-allergiques, et leur procede de preparation
MY102090A (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
FR2626279B1 (fr) Nouveaux derives de l'indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
EP0018675A3 (en) Lipogenesis inhibiting composition and process for its preparation
JPS54154735A (en) Production of 4-hydroxy-2-cycloalkenone
SE8303410D0 (sv) Benzene derivatives, processes for their preparation and pharmaceutical compositions comprising them
IE40929L (en) Substituted n-acyl -n''- (3- amino -2-¹cyano-acryloyl)-formamidrazones
ES8102144A2 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina
ES8106000A1 (es) Un procedimiento para la preparacion de pirimido-2-benzace- pinas

Legal Events

Date Code Title Description
ST Notification of lapse